Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
BMJ Open
|
June 24, 2022
<b>B</b>ea<b>r</b>berry in the treatment of acute unco<b>m</b>pl<b>i</b>cated cystitis (BRUMI): protocol of a multicentre, randomised double-blind clinical trial
Barbara Tóth, András Jávorházy, Péter Nyirády, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
July 29, 2024
Characterization of a colistin resistant, hypervirulent hospital isolate of Acinetobacter courvalinii from Canada
Ellen M E Sykes, Valeria Mateo-Estrada, Anna Muzaleva, et al.
Antimicrobial Agents and Chemotherapy
|
August 26, 2004
In vitro antimicrobial susceptibilities of Streptococcus pneumoniae clinical isolates obtained in Canada in 2002
Jeff Powis, Allison McGeer, Karen Green, et al.
Msphere
|
March 5, 2024
Phylogenomic and phenotypic analyses highlight the diversity of antibiotic resistance and virulence in both human and non-human <i>Acinetobacter baumannii</i>
Ellen M E Sykes, Valeria Mateo-Estrada, Raelene Engelberg, et al.
Journal of Global Antimicrobial Resistance
|
June 22, 2024
Real-life experience with IV dalbavancin in Canada; results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry
George Zhanel, Michael Silverman, Janhavi Malhotra, et al.
Emerging Infectious Diseases
|
April 4, 2012
Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009
James R Johnson, Marie-Hélène Nicolas-Chanoine, Chitrita DebRoy, et al.
Journal of Global Antimicrobial Resistance
|
April 8, 2023
Real-life experience with IV fosfomycin in Canada: Results from the Canadian LEadership on Antimicrobial Real-life usage (CLEAR) registry
George Zhanel, Melanie Baxter, Maggie Wong, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada
|
April 2, 2026
Invasive pneumococcal disease surveillance in Canada, 2023
Alyssa Golden, Averil Griffith, Brigitte Lefebvre, et al.
Canadian Family Physician Medecin De Famille Canadien
|
September 14, 2019
Vaccine strategies for prevention of community-acquired pneumonia in Canada: Who would benefit most from pneumococcal immunization?
Alan Kaplan, Pierre Arsenault, Brian Aw, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada
|
December 21, 2023
Invasive pneumococcal disease surveillance in Canada, 2020
Alyssa Golden, Averil Griffith, Walter Demczuk, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
BMJ Open
|
June 24, 2022
<b>B</b>ea<b>r</b>berry in the treatment of acute unco<b>m</b>pl<b>i</b>cated cystitis (BRUMI): protocol of a multicentre, randomised double-blind clinical trial
Barbara Tóth, András Jávorházy, Péter Nyirády, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
July 29, 2024
Characterization of a colistin resistant, hypervirulent hospital isolate of Acinetobacter courvalinii from Canada
Ellen M E Sykes, Valeria Mateo-Estrada, Anna Muzaleva, et al.
Antimicrobial Agents and Chemotherapy
|
August 26, 2004
In vitro antimicrobial susceptibilities of Streptococcus pneumoniae clinical isolates obtained in Canada in 2002
Jeff Powis, Allison McGeer, Karen Green, et al.
Msphere
|
March 5, 2024
Phylogenomic and phenotypic analyses highlight the diversity of antibiotic resistance and virulence in both human and non-human <i>Acinetobacter baumannii</i>
Ellen M E Sykes, Valeria Mateo-Estrada, Raelene Engelberg, et al.
Journal of Global Antimicrobial Resistance
|
June 22, 2024
Real-life experience with IV dalbavancin in Canada; results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry
George Zhanel, Michael Silverman, Janhavi Malhotra, et al.
Emerging Infectious Diseases
|
April 4, 2012
Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009
James R Johnson, Marie-Hélène Nicolas-Chanoine, Chitrita DebRoy, et al.
Journal of Global Antimicrobial Resistance
|
April 8, 2023
Real-life experience with IV fosfomycin in Canada: Results from the Canadian LEadership on Antimicrobial Real-life usage (CLEAR) registry
George Zhanel, Melanie Baxter, Maggie Wong, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada
|
April 2, 2026
Invasive pneumococcal disease surveillance in Canada, 2023
Alyssa Golden, Averil Griffith, Brigitte Lefebvre, et al.
Canadian Family Physician Medecin De Famille Canadien
|
September 14, 2019
Vaccine strategies for prevention of community-acquired pneumonia in Canada: Who would benefit most from pneumococcal immunization?
Alan Kaplan, Pierre Arsenault, Brian Aw, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada
|
December 21, 2023
Invasive pneumococcal disease surveillance in Canada, 2020
Alyssa Golden, Averil Griffith, Walter Demczuk, et al.
Page
of 4